ImmuneWorks, the Indianapolis-based biotechnology firm that specializes in the development of treatments for various lung diseases, has reached a joint agreement with LungRx that will fund research and development efforts for the next three years.
Creo Quality would like to congratulate Wade Lange and ImmuneWorks for this recent partnership with LungRx. To read more about the partnership, click here.
![Reblog this post [with Zemanta]](http://img.zemanta.com/reblog_e.png?x-id=c1a54330-8ab2-453c-bdf5-113ef389fae6)
